These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19808246)

  • 1. Can we personalize treatment for kidney diseases?
    Rovin BH; McKinley AM; Birmingham DJ
    Clin J Am Soc Nephrol; 2009 Oct; 4(10):1670-6. PubMed ID: 19808246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy for lupus nephritis--something old, something new.
    Balow JE; Austin HA
    N Engl J Med; 2004 Mar; 350(10):1044-6. PubMed ID: 14999117
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential therapies for proliferative lupus nephritis.
    Yee CS; Gordon C
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15190147
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential therapies for proliferative lupus nephritis.
    Farhey Y; Hess E
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195342
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment strategies for proliferative lupus nephritis: keep children in mind!
    Ranchin B; Fargue S
    Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapies for proliferative lupus nephritis.
    Gelber AC; Christopher-Stine L; Fine DM
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195341
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 9. Current treatment of lupus nephritis.
    Houssiau FA; Ginzler EM
    Lupus; 2008 May; 17(5):426-30. PubMed ID: 18490421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interdisciplinary consensus to management of lupus nephritis in Germany].
    de Groot K
    Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How did cyclophosphamide become the drug of choice for lupus nephritis?
    Bargman JM
    Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options for severe lupus nephritis.
    Lenz O; Contreras G
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):356-65. PubMed ID: 15507877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
    Urowitz MB; Ibañez D; Ali Y; Gladman DD
    J Rheumatol; 2007 Jul; 34(7):1491-6. PubMed ID: 17610320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Pharmacogenomics in Kidney Disease and Injury.
    Awdishu L; Joy MS
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):106-19. PubMed ID: 26979149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of SLE].
    Nakazawa T; Kumagai S; Kogata Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
    [No Abstract]   [Full Text] [Related]  

  • 18. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Karassa FB
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16481648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.